Emrify is launching a decentralized Personal Health Record platform on top of the Ethereum public blockchain to deliver trusted health information to the right hands at the right time anywhere in the world. With years of building consumer engagement mobile apps, Emrify is laser focused on collecting and locking up data for each person for complete ownership and control to freely share their data. Our top priority is to create attractive cryptoeconomics models to incentivize health data sharing for all parties. With strategic US partnerships with hospitals and doctors, Emrify is building on top of established prototypes to accelerate the launch of production interfaces to firmly establish the Utility Token in healthcare.

Based in the United States, Moonlighting is a 3-year-old freelance marketplace with a proven track record of empowering people to earn extra money and hire talented professionals quickly. With the integration of blockchain technology Moonlighting will decentralize worker profiles, reward participation, and make hiring and working in the freelance economy trusted, global, and inclusive.

Adrealm aims to rebuild the digital advertising ecosystem and cultivate a self-sustaining open ecosystem for all participants to achieve advertising efficiency. Built on ERC-20 standard of the Ethereum platform, Adrealm connects advertisers, service providers, content publishers, developers etc on its decentralized public ledger ensuring privacy and no third-party management of data. Thanks to its three-tier architecture made of an on-chain layer, off-chain layer, and a service layer, speed and efficiency can be guaranteed and the industry pain-points such as fraud, low-quality ads, and data leakage can be overcome. Adrealm relies on a particular consensus mechanism called Proof of Valid Traffic (PoVT) that makes high-quality ads and traffic the fundamental criteria for the operational success of transactions.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.

A blockchain-based integrative data marketplace for the global renewable energy industry. The REDi Infranet will empower various renewable energy producers, consumers, and industry experts to consolidate, verify, and distribute data in the search for improved productivity and efficiency towards true sustainability.

Lohn is a widely spread contractual form in various industrial fields of international cooperation relations, especially in the industry of clothing, footwear, leather, furniture, software and hardware, pharmaceutical, metal working, metallurgical, machine tools, automotive, automation, machine building industry, electronics and appliance industry, food and beverage industry, petrochemical industry. The lohn (processing economy) has been and will be a solution to produce goods at reasonable and high-quality prices through the efficient use of labor and cheap raw materials in emerging economies. It is also a business model that creates economic and social progress across the world bringing together markets with productive resources and capabilities. The trading platform developed by the lohncontrol project will create global opportunities for small and medium-sized businesses that are responsible for generating 60% of GDP. It will give them a visibility that they do not have at this time and will encourage the development of direct business between them. This means low manufacturing costs and greater adaptation to market demands. Those who will win at the end of this interaction will be consumers who will get good products at realistic prices.